TCL Archive In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge June 25, 1982
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty October 11, 2013
